Pressurized Intraperitoneal Aerosol Chemotherapy with Cisplatin and Doxorubicin in Women with Peritoneal Carcinomatosis: A Cohort Study

被引:1
作者
Tempfer, Clemens B. [1 ]
Rezniczek, Guenther A. [1 ]
Ende, Paula [1 ]
Solass, Wiebke [2 ]
Reymond, Marc-Andre [3 ]
机构
[1] Ruhr Univ Bochum, Dept Obstet & Gynecol, Bochum, Germany
[2] Hannover Med Sch, Inst Pathol, Hannover, Germany
[3] Ruhr Univ Bochum, Dept Surg, Bochum, Germany
关键词
Peritoneal metastasis; ovarian cancer; cisplatin; doxorubicin; intraperitoneal chemotherapy; pressure; aerosol; quality of life; RECURRENT OVARIAN-CANCER; INTRAABDOMINAL PRESSURE; PIPAC; HIPEC;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: We aimed to assess the objective tumor response (OTR) to laparoscopic pressurized intraperitoneal aerosol chemotherapy (PIPAC) in women with peritoneal carcinomatosis (PC). Patients and Methods: We carried-out a retrospective cohort study of women with PC undergoing repeated courses of PIPAC with 7.5 mg/m(2) of cisplatin and 1.5 mg/m(2) of doxorubicin. OTR was defined as histological regression. Peritoneal carcinomatosis index (PCI) improvement on video-laparoscopy and ascites volume reduction were secondary outcomes. Quality of life was assessed by the European Organization for Research & Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ)-30+3. Results: A total of 252 PIPACs were performed in 99 women with PC and ovarian (n=84), primary peritoneal (n=6), cervical (n=3), endometrial (n=3), fallopian tube (n=1), and breast (n=1) cancer and pseudomyxoma peritonei (n=1). Laparoscopic non-access rate was 17% (17/99). Fifty women had more than one PIPAC procedures, with an OTR of 76% (38/50) and PCI improvement in 64% (32/50). Ascites volume significantly decreased from 762 +/- 1170 ml to 167 +/- 456 ml (p=0.02). A high initial Karnofsky Index was correlated with receiving more than one PIPAC (p<0.0001) and a high number of previous surgeries with laparoscopic non-access (p=0.01). Twenty adverse events of Common Terminology Criteria for Adverse Events grade 3 or more were noted. Absence of ascites (odds ratio=8.45, 95% confidence interval=1.9-3.6; p<0.0001), but not patient age, serum cancer antigen-125, and Karnofsky Index independently predicted OTR. EORTC QLQ-30+3 scores for global physical health, nausea/vomiting, appetite loss, and constipation improved during therapy. Conclusion: PIPAC with cisplatin and doxorubicin is an active treatment in women with PC and preserves quality of life. Appropriate patient selection regarding performance status and the number of prior surgeries is important.
引用
收藏
页码:6723 / 6729
页数:7
相关论文
共 21 条
[1]  
[Anonymous], 2010, COMM TERM CRIT ADV E
[2]   Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: A French multicentre retrospective cohort study of 566 patients [J].
Bakrin, N. ;
Bereder, J. M. ;
Decullier, E. ;
Classe, J. M. ;
Msika, S. ;
Lorimier, G. ;
Abboud, K. ;
Meeus, P. ;
Ferron, G. ;
Quenet, F. ;
Marchal, F. ;
Gouy, S. ;
Morice, P. ;
Pomel, C. ;
Pocard, M. ;
Guyon, F. ;
Porcheron, J. ;
Glehen, O. .
EJSO, 2013, 39 (12) :1435-1443
[3]   Renal and Hepatic Toxicities After Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) [J].
Blanco, Ana ;
Giger-Pabst, Urs ;
Solass, Wiebke ;
Zieren, Juergen ;
Reymond, Marc A. .
ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (07) :2311-2316
[4]   High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis [J].
Esquis, Philippe ;
Consolo, David ;
Magnin, Guy ;
Pointaire, Philippe ;
Moretto, Philippe ;
Ynsa, Maria Dolores ;
Beltramo, Jean-Luc ;
Drogoul, Carole ;
Simonet, Michel ;
Benoit, Laurent ;
Rat, Patrick ;
Chauffert, Bruno .
ANNALS OF SURGERY, 2006, 244 (01) :106-112
[5]   Type-Specific Response to Neoadjuvant Chemotherapy: Ovarian High-Grade Serous Carcinoma Versus Colorectal Mucinous Carcinoma [J].
Glaze, Sarah ;
Nation, Jill ;
Kobel, Martin .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2012, 34 (07) :678-682
[6]   Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer The Multicenter Intergroup Study DESKTOP II. A Project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO [J].
Harter, Philipp ;
Sehouli, Jalid ;
Reuss, Alexander ;
Hasenburg, Annette ;
Scambia, Giovanni ;
Cibula, David ;
Mahner, Sven ;
Vergote, Ignace ;
Reinthaller, Alexander ;
Burges, Alexander ;
Hanker, Lars ;
Poelcher, Martin ;
Kurzeder, Christian ;
Canzler, Ulrich ;
Petry, Karl Ulrich ;
Obermair, Andreas ;
Petru, Edgar ;
Schmalfeldt, Barbara ;
Lorusso, Domenica ;
du Bois, Andreas .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (02) :289-295
[7]   Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration [J].
Jacquet, P ;
Stuart, OA ;
Chang, D ;
Sugarbaker, PH .
ANTI-CANCER DRUGS, 1996, 7 (05) :596-603
[8]   Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) [J].
Mazzei, Maria Antonietta ;
Khader, Leila ;
Cirigliano, Alfredo ;
Squitieri, Nevada Cioffi ;
Guerrini, Susanna ;
Forzoni, Beatrice ;
Marrelli, Daniele ;
Roviello, Franco ;
Mazzei, Francesco Giuseppe ;
Volterrani, Luca .
ABDOMINAL IMAGING, 2013, 38 (06) :1422-1430
[9]   Feasibility of therapeutic pneumoperitoneum in a large animal model using a microvaporisator [J].
Reymond, MA ;
Hu, B ;
Garcia, A ;
Reck, T ;
Köckerling, F ;
Hess, J ;
Morel, P .
SURGICAL ENDOSCOPY-ULTRASOUND AND INTERVENTIONAL TECHNIQUES, 2000, 14 (01) :51-55
[10]  
Robella M, 2014, MINERVA CHIR, V69, P27